Aridis Pharma Up Over 30% In 3 Trading Days, Awaits Phase 3 Data In Early 2020

Aridis Pharmaceuticals Inc. (ARDS), which has gained more than 30% so far this month, has a couple of clinical trial catalysts to watch out for in 2020.

from RTT - Biotech https://ift.tt/2T0irHW
via IFTTT